Record Revenue and Top‑End Like‑for‑Like Growth
Net revenues surpassed EUR 5.0 billion for FY2025, representing +7.8% like‑for‑like growth and +5.3% reported growth — at the top end of guidance (6%–8% LFL). Q4 net revenues reached EUR 1.45 billion with 9.8% like‑for‑like growth.
Strong Profitability and Cash Generation
Gross profit margin improved to 75.1% (up ~19 bps vs. 2024). Adjusted EBITDA was EUR 1.045 billion with a margin of 20.7% (+49 bps vs. 2024). Adjusted net profit was EUR 587 million (+6.5% YoY) and free cash flow conversion was 64% of adjusted EBITDA.
Makeup Segment Outperformance (Charlotte Tilbury-led)
Makeup revenues reached EUR 845 million, up +13.7% like‑for‑like (Q4 like‑for‑like +26.5%). Charlotte Tilbury delivered exceptional performance, expanded distribution (Amazon U.S., new market Mexico), and retained strong ranking (#1 UK prestige makeup, #3 U.S.).
High Growth in Asia Pacific
Asia Pacific was the fastest‑growing region with EUR 530 million in sales and +21.7% like‑for‑like growth for FY2025 (Q4 +18.9% LFL), driven by Charlotte Tilbury, Niche and Derma brands (noting some benefit from consolidation effects not expected to repeat).
Fragrance & Fashion Resilience and Market Position
Fragrance & Fashion (72% of group revenues) delivered EUR 3.6 billion and +6.4% like‑for‑like growth. Puig defended global value market share at 11.1% and saw double‑digit outperformance from its Niche portfolio (Byredo) and strong performances from Carolina Herrera and Jean Paul Gaultier.
Skincare Delivered Consistent Growth
Skincare revenues were EUR 551 million, up +8.9% like‑for‑like (Q4 EUR 141 million, +7.9% LFL). Growth led by Uriage (double‑digit) and supported by Charlotte Tilbury skincare and new product launches.
Improved Balance Sheet and Capital Allocation
Net debt reduced to EUR 716 million (leverage 0.7x net debt/adjusted EBITDA, ~0.4x improvement YoY). Operational cash flow improved to EUR 684 million; CapEx ~4% of net revenues. Board proposed a 40% payout ratio translating to EUR 237 million dividend (EUR 0.42/share, subject to AGM).
Operational Progress and Strategic Momentum
Completed previous 5‑year strategic plan (more than tripled 2020 revenue by 2025). Ongoing operational initiatives include transition of Chartres production plant (move to new site by H1 2027) and a planned Capital Markets Day on April 14, 2026 to present the next roadmap.